Validation of the ASDAS with a quick quantitative CRP assay (ASDAS-Q) in patients with axial SpA: a prospective multicentre cross-sectional study.

Ther Adv Musculoskelet Dis · 2022 · PMC8972926 · PMID 35368376

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

32 Nevertheless, a positive trend for all outcomes in the T2T group as well as higher cost-effectiveness was observed. 32 The treatment target in the TICOSPA trial was an ASDAS <2.1 32 allowing also ‘low disease activity’ and not only ‘inactive disease’.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.